New drug mimics IVIg to fight low platelet disorder
NCT ID NCT07095127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called NVG-2089 in 30 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The drug is designed to work like IVIg, calming the immune system. Researchers will check for side effects and see if it raises platelet counts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NVG-2089
What this could lead to
If successful, this could provide a new treatment option for people with immune thrombocytopenia, helping to raise platelet counts and reduce bleeding risk.
What could go wrong
This is an early Phase 2 trial with only 30 participants, so results may not apply to everyone. The drug may cause side effects or fail to improve platelet counts significantly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA (ITP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
East Carolina University
RECRUITINGGreenville, North Carolina, 27834, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••